Hepatitis Clinical Trials in New York

Showing 21-40 of 155 trials

HCV Test and Treat Utilizing Simplified HCV Patient Education

NCT05582681

The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.

Hepatitis C

Weill Medical College of Cornell University8 participantsStarted Nov 2022

Long Island City, New York, United States • New York, New York, United States • New York, New York, United States

COMPLETEDPHASE2< 1 mile

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

NCT03982186

The purpose of this study is to establish the dose-response relationship for antiviral activity of 3 dose levels of JNJ-73763989+nucleos(t)ide analog (NA) and to evaluate the efficacy of combination regimens of JNJ-73763989+NA (with and without JNJ-56136379) and of JNJ-56136379+NA.

Hepatitis B, Chronic

Janssen Sciences Ireland UC471 participantsStarted Aug 2019

Bakersfield, California, United States • Los Angeles, California, United States • San Clemente, California, United States +105 more locations

HCV Test and Treat Utilizing Simplified HCV Patient Education

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

Hepatitis Trials in Other Cities

Computer-based Intervention for Alcohol-using HIV/HCV+ Women

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

HCV Seek, Test and Rapid Treatment for Young PWID

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Rapid Diagnostics for HIV and Hepatitis

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Patient-Centered Models of HCV Care for People Who Inject Drugs

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Alcoholic Hepatitis Network Observational Study

HBV-HIV Coinfection Research Network

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

A Phase 2b Study of Icosabutate in Fatty Liver Disease

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

LITMUS Imaging Study

Other Conditions in New York